1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 262 F.Supp.2d
  5. 262 F.Supp.2d 17 (2003)
 

IN RE TAMOXIFEN CITRATE ANTITRUST LITIGATION

No. MDL.NO. 1408 ILG.

262 F.Supp.2d 17 (2003)

In re TAMOXIFEN CITRATE ANTITRUST LITIGATION

United States District Court, E.D. New York.

May 15, 2003.

Attorney(s) appearing for the Case

Barbara J. Hart, Bernard Persky, Hollis L. Salzman, Goodkind, Labaton, Rudoff & Sucharow, LLP, New York City, Joel M. Cohen, Davis, Polk & Wardwell, New York City, Michael J. Flannery, The David Danis Law Firm, P.C., St. Louis, MO, for In Re Tamoxifen Citrate Antitrust Litigation.

CORRECTED MEMORANDUM AND ORDER

GLASSER, District Judge.

SUMMARY

Defendant AstraZeneca PLC appears specially to move to dismiss the claims against it for lack of personal jurisdiction pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure. Plaintiffs allege that AstraZeneca PLC (by its purported predecessor in interest Zeneca Limited and with its subsidiaries and co-defendants Zeneca, Inc. and Astrazeneca Pharmaceuticals...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases